Diterpenoid alkaloids isolated from Delphinium trichophorum alleviate pulmonary fibrosis via the TGF-β/Smad pathway in 3T6 and HFL-1 cells.
Alkaloids
/ pharmacology
Delphinium
/ metabolism
Diterpenes
/ therapeutic use
Fibrosis
Lipopolysaccharides
/ pharmacology
Molecular Docking Simulation
Pulmonary Fibrosis
/ chemically induced
Receptor, Transforming Growth Factor-beta Type I
/ metabolism
Signal Transduction
Smad Proteins
/ metabolism
Transforming Growth Factor beta
/ metabolism
Transforming Growth Factor beta1
/ metabolism
Delphinium trichophorum Franch
Diterpenoid alkaloids
Fibroblasts
Pulmonary fibrosis
TGF-β/Smad signaling pathway
Journal
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
ISSN: 1950-6007
Titre abrégé: Biomed Pharmacother
Pays: France
ID NLM: 8213295
Informations de publication
Date de publication:
May 2022
May 2022
Historique:
received:
26
01
2022
revised:
19
03
2022
accepted:
27
03
2022
entrez:
7
9
2022
pubmed:
8
9
2022
medline:
9
9
2022
Statut:
ppublish
Résumé
Delphinium trichophorum Franch (DTF), a species endemic to China, has been widely used for centuries in Tibet as an indigenous medicine for treating cough, pneumonia, and pulmonary fibrosis. Hetisine-type C
Identifiants
pubmed: 36068772
pii: S0753-3322(22)00295-5
doi: 10.1016/j.biopha.2022.112906
pii:
doi:
Substances chimiques
Alkaloids
0
Diterpenes
0
Lipopolysaccharides
0
Smad Proteins
0
Transforming Growth Factor beta
0
Transforming Growth Factor beta1
0
Receptor, Transforming Growth Factor-beta Type I
EC 2.7.11.30
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
112906Informations de copyright
Copyright © 2022 The Authors. Published by Elsevier Masson SAS.. All rights reserved.